EFFECTS OF SODIUM THIOSULFATE VERSUS OBSERVATION ON DEVELOPMENT OF CISPLATIN-INDUCED HEARING LOSS IN CHILDREN WITH CANCER: RESULTS FROM THE CHILDREN’S ONCOLOGY GROUP ACCL0431 RANDOMISED CLINICAL TRIAL

BACKGROUND: Sodium thiosulfate (STS) is an antioxidant shown in preclinical studies to prevent cisplatin-induced hearing loss (CIHL) but not compromise anti-tumour efficacy with timed administration post-cisplatin. The primary study aim was to evaluate STS for prevention of CIHL. METHODS: ACCL0431 w...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Lancet Oncol
Главные авторы: Freyer, David R., Chen, Lu, Krailo, Mark D., Knight, Kristin, Villaluna, Doojduen, Bliss, Bonnie, Pollock, Brad H., Ramdas, Jagadeesh, Lange, Beverly, Van Hoff, David, VanSoelen, Michele L., Wiernikowski, John, Neuwelt, Edward A., Sung, Lillian
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520988/
https://ncbi.nlm.nih.gov/pubmed/27914822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30625-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы